Proscia to Broaden Pathology AI Capabilities with Biomarker Detection for Skin Tissue

Proscia: Expanding the industry’s most comprehensive portfolio of AI applications  PHILADELPHIA and PARIS—October 15, 2025—Proscia®, a pathology AI company, will add AI biomarker detection for skin tissue to...

Indica Labs explores the capabilities and workflow of newest HALO module Highly multiplexed imaging is changing the way that we view and understand tissues and is helping to elucidate previously unrecognized cellular populations and...

Aiforia: A significant milestone in enhancing workflows and improving diagnostic quality and consistency in their pathology laboratory. Aiforia Technologies Plc, Press Release, October 13, 2025, at 10:00 a.m. EEST Aiforia Technologies’...

Lumea and Valar Labs today announced a partnership to integrate Valar Labs' Vesta tests into the Lumea digital pathology platform. LEHI, UT, UNITED STATES, October 9, 2025 /EINPresswire.com/ -- Lumea, the U.S. leader in primary clinical...

Indica Labs: Learn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy! Multi-omics analysis demonstrates repetitive head impacts induce neuronal loss and neuroinflammation...

The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...